Buy PETHISCOT 50mg|ml Injection 1mlx100s Online At Best Price In Pakistan

Dosage

Missed Dose

Oral: Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Injections: Since this medicine is usually administered by a qualified healthcare professional before and during a surgical procedure in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Oral: Seek emergency medical treatment or contact the doctor in case of an overdose. Injections: Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions

Tramadol   (severe)

Monoamine oxidase inhibitors   (severe)

Alprazolam   (severe)

Citalopram   (severe)

Fluvoxamine   (severe)

Granisetron   (severe)

Prescribes

Moderate to severe pain

This medicine is used to relieve moderate to severe pain associated with surgery, labor, etc.

Side Effects

Drug dependence   (severe)

Hallucinations   (severe)

Dizziness and Drowsiness   (severe)

Headache   (severe)

Decreased heart rate   (severe)

Nausea and vomiting  

Constipation  

Dry mouth  

Itching and skin rash  

Muscle rigidity  

Difficulty in urination   (severe)

Decreased libido   (severe)

Warnings

Administer with caution

Drug dependence and tolerance

Intracranial pressure

Biliary spasm

Driving and Operating machinery

Pregnancy

Breast-feeding

When Not To Use

Allergy

This medicine is not recommended for use in patients with a known allergy to PETHISCOT 50mg|ml Injection 1mlx100s or any other inactive ingredients present along with it.

Respiratory depression

This medicine is not recommended for use in patients with respiratory depression due to the increased risk of worsening of the patient's condition.

Acute or severe bronchial asthma

This medicine is not recommended for use in patients with acute or severe bronchial asthma in absence of resuscitative equipment or monitoring due to the increased risk of worsening of the patient's condition.

Coma

This medicine is not recommended for use in comatose patients due to the increased risk of worsening of the patient's condition.

Monoamine oxidase inhibitors (MAO)

This medicine is not recommended for use in patients taking monoamine oxidase inhibitors (MAOI) due to the increased risk of serious and life-threatening side effects. A time gap of at least 14 days should be maintained between stopping therapy with MAOIs and starting therapy with this medicine.

Paralytic ileus

This medicine is not recommended for use in patients with gastrointestinal obstruction, including paralytic ileus due to the increased risk of worsening of the patient's condition.

Diabetic ketoacidosis

This medicine is not recommended for use in patients with diabetic ketoacidosis who are at risk of coma due to the increased risk of worsening of the patient's condition.

Acute alcoholism

This medicine is not recommended for use in patients with acute alcoholism due to the increased risk of worsening of the patient's condition.